Improving Shared Decision-Making for Adults with Stage II-IV Non-Small Cell Lung Cancer Using a Communication Tool During Clinical Visits

What this Trial Is About

Researchers are evaluating a shared decision-making communication tool to improve the quality of discussions between patients with non-small cell lung cancer NSCLC and their clinicians. The study aims to see if using this tool during clinical visits enhances the decision-making process and reduces patients doubts about their treatment choices compared to standard care alone. The trial focuses on adult NSCLC patients eligible for adjuvant treatment, highlighting the importance of patient involvement in choosing their care. Participants are randomly assigned to one of two groups one group receives standard care visits with their clinician, while the other group receives standard care plus the use of the shared decision-making conversation tool during the visit. After these clinical encounters, patients are followed up at 2 and 6 weeks to assess the impact of the tool. Additional study activities include reviews of electronic health records and collecting surveys, video, and audio recordings as part of ancillary studies. During the study, researchers measure how well the shared decision-making process is implemented immediately after appointments and again at 2 weeks. They also assess how involved patients feel in decisions and gather feedback from clinicians about using the conversation tool after each encounter. The total participation involves the initial clinical visit plus follow-ups at two time points to monitor outcomes related to decision quality and satisfaction.

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer